Tag: OSE Immunotherapeutics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to OSE Immunotherapeutics

Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy

Added to Collection on: 2019-03-26 21:18:45

Tags for this article:

Medicine
Clinical medicine
Cancer
Cancer treatments
Immunotherapy
Cancer immunotherapy
Chemotherapy
Treatment of cancer
Checkpoint inhibitor
Antineoplastic resistance
OSE Immunotherapeutics

Click the tags to see associated articles and topics

View Article Details
OSE Immunotherapeutics to Present at SITC Annual Meeting and at Additional International ...

Added to Collection on: 2020-11-09 00:52:30

Tags for this article:

Boehringer Ingelheim
Cancer immunotherapy
Cancer research
CD47
Clinical medicine
Clusters of differentiation
Immune checkpoint
Immune system
Medical specialties
Medicine
Monoclonal antibody
OSE Immunotherapeutics
Signal-regulatory protein alpha

Click the tags to see associated articles and topics

View Article Details
OSE Immunotherapeutics Expands its Collaboration with MAbSilico to Use Artificial Intelligence to ...

Added to Collection on: 2021-01-28 16:52:30

Tags for this article:

Medical specialties
Medicine
Clinical medicine
Immunology
Monoclonal antibody
Boehringer Ingelheim
Antibody
Cancer immunotherapy
Humanized antibody
CD47
OSE Immunotherapeutics
MAbSilico MAbSilico

Click the tags to see associated articles and topics

View Article Details
OSE Immunotherapeutics and Veloxis Pharmaceuticals Enter Into Global License Agreement to ...

Added to Collection on: 2021-04-27 12:33:45

Tags for this article:

Clinical medicine
Medicine
Medical specialties
Immunology
Boehringer Ingelheim
Monoclonal antibody
Cancer immunotherapy
Organ transplantation
Immunotherapy
Veloxis Pharmaceuticals Inc.
OSE Immunotherapeutics

Click the tags to see associated articles and topics

View Article Details
OSE Immunotherapeutics Announces Upcoming Investor Conferences and R&D Day

Added to Collection on: 2021-08-24 15:56:15

Tags for this article:

Clinical medicine
Medicine
Drugs
Antineoplastic drugs
Breakthrough therapy
Orphan drugs
Boehringer Ingelheim
Cancer research
Cancer immunotherapy
Nivolumab
Monoclonal antibody
Pembrolizumab
OSE Immunotherapeutics

Click the tags to see associated articles and topics

View Article Details
OSE Immunotherapeutics Receives U.S. Patent Notice of Allowance for Tedopi® - Yahoo Finance

Added to Collection on: 2021-09-07 05:26:15

Tags for this article:

Cancer treatments
Clinical medicine
Drugs
Breakthrough therapy
Orphan drugs
Cancer immunotherapy
Antineoplastic drugs
Bristol-Myers Squibb
Boehringer Ingelheim
Nivolumab
Pembrolizumab
Lung cancer
OSE Immunotherapeutics

Click the tags to see associated articles and topics

View Article Details